These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35307762)

  • 1. Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?
    Ling C
    Diabetologia; 2022 Nov; 65(11):1849-1853. PubMed ID: 35307762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoepigenetics: an element of personalized therapy?
    Majchrzak-Celińska A; Baer-Dubowska W
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):387-398. PubMed ID: 27860490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving pharmacoepigenetics tools for depression toward clinical use.
    Hack LM; Fries GR; Eyre HA; Bousman CA; Singh AB; Quevedo J; John VP; Baune BT; Dunlop BW
    J Affect Disord; 2019 Apr; 249():336-346. PubMed ID: 30802699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic changes in gene expression for drug-metabolizing enzymes and transporters.
    Kim IW; Han N; Burckart GJ; Oh JM
    Pharmacotherapy; 2014 Feb; 34(2):140-50. PubMed ID: 24166985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics of type 2 diabetes mellitus and weight change - a tool for precision medicine?
    Ling C; Bacos K; Rönn T
    Nat Rev Endocrinol; 2022 Jul; 18(7):433-448. PubMed ID: 35513492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes.
    Ling C
    J Intern Med; 2020 Aug; 288(2):158-167. PubMed ID: 32363639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoepigenetics and Pharmacoepigenomics: An Overview.
    Peedicayil J
    Curr Drug Discov Technol; 2019; 16(4):392-399. PubMed ID: 29676232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: A systematic review.
    Muka T; Nano J; Voortman T; Braun KVE; Ligthart S; Stranges S; Bramer WM; Troup J; Chowdhury R; Dehghan A; Franco OH
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):553-566. PubMed ID: 27146363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.
    Lopomo A; Coppedè F
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):49-62. PubMed ID: 28856927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.
    Hossan T; Kundu S; Alam SS; Nagarajan S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):775-786. PubMed ID: 30827271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics in Human Obesity and Type 2 Diabetes.
    Ling C; Rönn T
    Cell Metab; 2019 May; 29(5):1028-1044. PubMed ID: 30982733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promises and challenges in pharmacoepigenetics.
    Smith DA; Sadler MC; Altman RB
    Camb Prism Precis Med; 2023; 1():e18. PubMed ID: 37560024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modifications: An important mechanism in diabetic disturbances.
    Rorbach-Dolata A; Kubis A; Piwowar A
    Postepy Hig Med Dosw (Online); 2017 Nov; 71(0):960-974. PubMed ID: 29225202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Modifications Linked to T2D, the Heritability Gap, and Potential Therapeutic Targets.
    Szabó M; Máté B; Csép K; Benedek T
    Biochem Genet; 2018 Dec; 56(6):553-574. PubMed ID: 29872933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy is associated with epigenetic modifications in individuals with Type 2 diabetes.
    Schrader S; Perfilyev A; Martinell M; García-Calzón S; Ling C
    Epigenomics; 2021 Jun; 13(12):919-925. PubMed ID: 33947200
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacoepigenetics in heart failure.
    Mateo Leach I; van der Harst P; de Boer RA
    Curr Heart Fail Rep; 2010 Jun; 7(2):83-90. PubMed ID: 20424992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic markers to further understand insulin resistance.
    Ling C; Rönn T
    Diabetologia; 2016 Nov; 59(11):2295-2297. PubMed ID: 27650286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics in β-cell adaptation and type 2 diabetes.
    Kim H; Kulkarni RN
    Curr Opin Pharmacol; 2020 Dec; 55():125-131. PubMed ID: 33232934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics and Type 2 Diabetes Risk.
    Dhawan S; Natarajan R
    Curr Diab Rep; 2019 Jun; 19(8):47. PubMed ID: 31250127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic markers associated with metformin response and intolerance in drug-naïve patients with type 2 diabetes.
    García-Calzón S; Perfilyev A; Martinell M; Ustinova M; Kalamajski S; Franks PW; Bacos K; Elbere I; Pihlajamäki J; Volkov P; Vaag A; Groop L; Maziarz M; Klovins J; Ahlqvist E; Ling C
    Sci Transl Med; 2020 Sep; 12(561):. PubMed ID: 32938793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.